UP!

RNN $5.24

RNN target price
5.24
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2019 2019-05-06 0.00 0.00
Q4 2018 2019-03-08 -1.08 -1.08
Q3 2018 2018-11-02 -2.04 -2.04

Ratings

2016-03-27 Reiterated Rating FBR & Co. Buy $3.00
2016-02-29 Reiterated Rating Roth Capital Buy $1.75
2016-02-10 Reiterated Rating FBR & Co. Outperform $3.00
2015-11-03 Reiterated Rating Roth Capital Buy $3.00
2015-09-29 Reiterated Rating Roth Capital Buy $3.00
2015-08-14 Reiterated Rating MLV & Co. Buy $1.25
2015-08-11 Reiterated Rating Roth Capital Buy $3.00
2015-05-13 Reiterated Rating Roth Capital Buy $3.00
2015-03-20 Initiated Coverage MLV & Co. Buy $1.25
2014-09-16 Initiated Coverage Laidlaw Buy $3.50
2014-03-24 Initiated Coverage Brinson Patrick Outperform
2014-01-09 Initiated Coverage Roth Capital Buy $3.00
2011-06-16 Resumed Brean Murray Buy $3
2016-03-27 Reiterated Rating FBR & Co. Buy $3.00
2016-02-29 Reiterated Rating Roth Capital Buy $1.75
2016-02-10 Reiterated Rating FBR & Co. Outperform $3.00
2015-11-03 Reiterated Rating Roth Capital Buy $3.00
2015-09-29 Reiterated Rating Roth Capital Buy $3.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In RNN 5 funds of 2213 total. Show all

Fund name Ticker shares
BlackRock Institutional Trust Company, N.A. 0.33M
BlackRock Fund Advisors 56586
BLACKROCK ADVISORS LLC 44878
WFG Advisors, LP 500
Hoxton Financial, Inc. 422

Major Shareholders

Name Relationship Total Shares Holding stocks
Ahn Chang Ho 3.37%  (6010000) RNN /
Rexgene Biotech Co., Ltd. 3.09%  (5505956) RNN /
Park Young Soon 1.14%  (2040500) RNN /
Rhee Jang Han 1.12%  (2000000) RNN /
Jeong Tae Heum CFO and Secretary 0.28%  (505000) RNN /
Brandt Peter C. 0.08%  (150000) AUXL / RNN /
Kwon Suk Hyung 0.06%  (114255) RNN /
McIntosh David M 0.01%  (25990) RNN /
Suzdak Peter David Chief Executive Officer 0.01%  (22250) RNN /
Kang Y Michele 0.01%  (10000) RNN /
Beever Charles 0.01%  (10000) RNN /